Search

Search Results
Results 51 - 60 of 998 for Disease detection
  • Supplier Profile
    The Project on Emerging Nanotechnologies was established in April 2005 as a partnership between the Woodrow Wilson International Center for Scholars and the Pew Charitable Trusts. The Project is...
  • Supplier Profile
    The Center is the living, national memorial to President Wilson established by Congress in 1968 and headquartered in Washington, D.C. It is a nonpartisan institution, supported by public and private...
  • Supplier Profile
    Since 1949, Sandia National Laboratories has developed science-based technologies that support our national security. Today, the nearly 300 million Americans depend on Sandia's technology...
  • Supplier Profile
    Established in 1947 on Long Island, Upton, New York, Brookhaven is a multi-program national laboratory operated by Brookhaven Science Associates for the U.S. Department of Energy (DOE). Six Nobel...
  • Supplier Profile
    Nanowear has produced the first FDA 510(k) cleared cloth-based nanotechnology monitoring platform, bringing health monitoring into high definition with unmatched patient experience. Millions of...
  • Article - 12 Aug 2005
    Building synthetic organisms with DNA segments at nanoscale level offers scientists a wide range of opportunities in the areas such as gene therapy and disease detection. This articles focuses on...
  • Article - 1 Aug 2005
    Nanotechnology enhances disease detection and drug delivery using biolabels like dendrimers and magnetic nanoparticles for early diagnosis and targeted therapy.
  • Article - 28 Jun 2005
    Research in the field of nanobiotechnology could help to improve the ways in which cancer is detected and treated. Medical imaging, labeling methods, quantum dots, nanosensors, lab on a chip devices,...
  • Article - 19 May 2005
    Bionanotechnology is a result of the convergence of biotechnology and nanotechnology.
  • News - 18 Jul 2022
    Although blood-biomarker-based tests help in the early diagnosis of Alzheimer’s disease, the low abundance of blood protein biomarkers related to Alzheimer’s disease and the complexity of...

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.